New test shown to be 100% effective at detecting cervical cancer

NewsGuard 100/100 Score

Researchers at the Queen Mary University of London have developed a new cervical cancer test that proved to be 100% effective at detecting the cancer in a trial of 15,744 participants.

cervical cancer cells taken from pap smear test for cervical cancer - By Komsan Loonpro

Komsan Loonproom | Shutterstock

The study demonstrated that the epigenetics-based test outperformed both the Pap smear and the human papilloma virus (HPV) test, as well as being more cost effective.

As reported in the International Journal of Cancer, lead researcher Dr. Attila Lorincz and team assessed how well the test predicted the development of cervical cancer up to five years in advance, compared with the PAP smear and HPV tests.

This is an enormous development. We’re not only astounded by how well this test detects cervical cancer, but it is the first time that anyone has proven the key role of epigenetics in the development of a major solid cancer using data from patients in the clinic.”

Dr. Attila Lorincz

Lorincz adds that in contrast to what the majority of researchers are saying, there is a growing body of evidence that it is epigenetics rather than DNA mutations that drive a wide range of early cancers, including cervical, colon prostate and oropharyngeal.

The Pap smear is the most common screening method for preventing cervical cancer, despite only being able to detect ~50% of pre-cancers.

A far more accurate test involves looking for DNA from Human Papilloma Virus (HPV), the primary cause of cervical cancer. However, this test only identifies whether women are infected with HPV and not the actual cancer risk. The issue with this test is that the majority of women infected with HPVeventually clear the virus and do not go on to develop disease.

The new test significantly outperformed both the Pap smear and HPV test, detecting 100% of the invasive cervical cancers that developed during the trial.

By contrast, the Pap smear only detected one quarter of the cancers and the HPV test detected half.

We were surprised by how well this new test can detect and predict early cervical cancers years in advance, with 100 per cent of cancers detected, including adenocarcinomas, which is a type of cervical cancer that is very difficult to detect.”

Dr. Attila Lorincz

The researchers say that since the new test can detect high-grade cervical cancer in its early stages, implementation in the clinic would reduce the number of visits to the doctor and screening appointments, whilst providing a cheaper way of detecting the disease.

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2023, March 11). New test shown to be 100% effective at detecting cervical cancer. News-Medical. Retrieved on April 13, 2024 from

  • MLA

    Robertson, Sally. "New test shown to be 100% effective at detecting cervical cancer". News-Medical. 13 April 2024. <>.

  • Chicago

    Robertson, Sally. "New test shown to be 100% effective at detecting cervical cancer". News-Medical. (accessed April 13, 2024).

  • Harvard

    Robertson, Sally. 2023. New test shown to be 100% effective at detecting cervical cancer. News-Medical, viewed 13 April 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.